Liver mitochondrial function and redox status in an experimental model of non-alcoholic fatty liver disease induced by monosodium l-glutamate in rats

Experimental and Molecular Pathology

Volumn 91, Issue 3, 2011, Pages 687-694

  Lazarin, Murilo de Oliveira ^a   Ishii Iwamoto, Emy Luiza ^a   Yamamoto, Nair Seiko ^a   Constantin, Rodrigo Polimeni ^a   Garcia, Rosângela Fernandes ^a   da Costa, Cecília E Mareze ^a   Vitoriano, Adriana de Souza ^a   de Oliveira, Monique Cristine ^a   Salgueiro Pagadigorria, Clairce L ^a  

^a STATE UNIVERSITY OF MARINGÁ   (Brazil)

Author keywords

Mitochondria; MSG; NAFLD; Obesity; Oxidative stress; ROS

Indexed keywords

ADENOSINE TRIPHOSPHATASE; CALCIUM ION; CATALASE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; REACTIVE OXYGEN METABOLITE; SUCCINIC ACID; SUPEROXIDE DISMUTASE; THIOL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; CELL FUNCTION; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENZYME ACTIVITY; ENZYME HISTOCHEMISTRY; EXPERIMENTAL RAT; FATTY ACID OXIDATION; ISOLATED LIVER; LIPID BLOOD LEVEL; LIVER MITOCHONDRION; MALE; MITOCHONDRIAL PERMEABILITY; MITOCHONDRION SWELLING; MOLECULAR PATHOLOGY; NEWBORN; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; OXIDATION REDUCTION STATE; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; OXYGEN CONSUMPTION; RAT; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; ANIMALS, NEWBORN; FATTY LIVER; GLUCOSEPHOSPHATE DEHYDROGENASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; MALE; MITOCHONDRIA, LIVER; OBESITY; OXIDATION-REDUCTION; OXIDATIVE PHOSPHORYLATION; RATS; RATS, WISTAR; SODIUM GLUTAMATE;

RATTUS;

EID: 80053519285     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2011.07.003     Document Type: Article

References (73)

1. Adams L.A., Angulo P. Recent concepts in non-alcoholic fatty liver. Diabet. Med. 2005, 22:1129-1133.
2. Adams L.A., Angulo P., Lindor K.D. Nonalcoholic fatty liver disease. CMAJ 2005, 172:899-905.
3. Aebi H. Catalase. Methods of enzymatic analysis 1974, 673-690. Academic Press, New York. H.U. Bergmeyer (Ed.).
4. Baffy G., Zhang C.Y., Glickman J.N., Lowell B.B. Obesity-related fatty liver is unchanged in mice deficient for mitochondrial uncoupling protein 2. Hepatology 2002, 35:753-761.
5. Balbo S.L., Grassiolli S., Ribeiro R.A., Bonfleur M.L., Gravena C., Brito M.N., Andreazzi A.E., Freitas Mathias P.C., Torrezan R. Fat storage is partially dependent on vagal activity and insulin secretion of hypothqlamic obese rat. Endocr. 2007, 31:142-148.
6. Begriche K., Igoudjil A., Pessayre D., Fromenty B. Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it. Mitochondrion 2006, 6:1-28.
7. Bernardi P. Modulation of the mitochondrial cyclosporin A-sensitive permeability transition pore by the proton electrochemical gradient. Evidence that the pore can be opened by membrane despolarization. J. Biol. Chem. 1992, 267:8834-8839.
8. Bernardis L.L., Patterson B.D. Correlation between 'Lee index' and carcass fat content in weanling and adult female rats with hypothalamic lesions. J. Endocrinol. 1968, 40:527-528.
9. Berson A., De Beco V., Lettéron P., Robin M.A., Moreau C., El Kahwaji J., Verthier N., Feldmann G., Fromenty B., Pessayre D. Steatohepatitis-inducing drugs cause mitochondrial dysfunction and lipid peroxidation in rat hepatocytes. Gastroenterology 1998, 114:764-774.
10. Boss O., Hagen T., Lowell B.B. Uncoupling proteins 2 and 3: potential regulators of mitochondrial energy metabolism. Diabetes 2000, 49:143-156.
11. Bracht A., Ishii-Iwamoto E.L., Salgueiro-Pagadigorria C.L. Técnicas de centrifugação e de fracionamento celular. Métodos de laboratório em bioquímica 2003, 77-101. Manole Ltda, São Paulo. A. Bracht, E.L. Ishii-Iwamoto (Eds.).
12. Bracht A., Ishii-Iwamoto E.L., Salgueiro-Pagadigorria C.L. O estudo do metabolismo energético em mitocÔndrias isoladas de tecido animal. Métodos de laboratório em bioquímica 2003, 227-247. Manole Ltda, São Paulo. A. Bracht, E.L. Ishii-Iwamoto (Eds.).
13. Brady L.J., Brady P.S., Romsos D.R., Hoppel C.L. Elevated hepatic mitochondrial and peroxisomal oxidative capacities in fed and starved adult obese (ob/ob) mice. Biochem. J. 1985, 231:439-444.
14. Chakravarthy M.V., Pan Z., Zhu Y., Tordjman K., Schneider J.G., Coleman T., Turk J., Semenkovich C.F. 'New' hepatic fat activates PPARα to maintain glucose, lipid and cholesterol homeostasis. Cell. Metab. 2005, 1:309-322.
15. Chance B., Williams G.R. A simple and rapid assay of oxidative phosphorylation. Nature 1955, 175:1120-1121.
16. Charlton M., Kasparova P., Weston S., Lindor Maor-Kendler Y., Wiesner R.H., Rosen C.B., Batts K.B. Frequency of nonalcoholic steatohepatitis as a cause of advanced liver disease. Liver Transpl. 2001, 7:608-614.
17. Chavin K.D., Yang S., Lin H.Z., Chatham J., Chacko V.P., Hoek J.B., Walajtys-Rode E., Rashid A., Chen C.H., Huang C.C., Wu T.C., Lane M.D., Diehl A.M. Obesity induces expression of uncoupling protein-2 in hepatocytes and promotes liver ATP depletion. J. Biol. Chem. 1999, 274:5692-5700.
18. Cortez-Pinto H., Lin Z.H., Yang Q.S., Da Costa O.S., Diehl A.M. Lipids upregulate uncoupling protein 2 expression in rat hepatocytes. Gastroenterology 1999, 116:1184-1193.
19. Crompton M., Virji S., Doyle V., Johnson N., Ward J.M. The mitochondrial permeability transition pore. Biochem. Soc. Symp. 1999, 66:167-179.
20. Day C., James O. Steatohepatitis: a tale of two "hits"?. Gastroenterology 1998, 114:842-845.
21. De Craemer D., Pauwels M., Van den Branden C. Alterations of peroxisomes in steatosis of the human liver: a quantitative study. Hepatology 1995, 22:744-752.
22. De Mello M.A., De Souza C.T., Braga L.R., Dos Santos J.W., Ribeiro I.A., Gobatto C.A. Glucose tolerance and insulin action in monosodium glutamate (MSG) obese exercise-trained rats. Physiol. Chem. Phys. Med. NMR 2001, 33:63-71.
23. Ellman G.L., Courtney K.D., Andres V., Featherstone R.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 1961, 7:88-95.
24. Evans C.D., Oien K.A., MacSween R.N.M., Mills P.R. Non-alcoholic steatohepatites: a common cause of progressive chronic injury?. J. Clin. Pathol. 2002, 55:689-692.
25. Fiske C.H., Subbarow Y. The colorimetric determination of phosphorus. J. Biol. Chem. 1925, 66:375-400.
26. Folch J., Lees M., Sloane Stanley G.H. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 1957, 226:497-509.
27. Fromenty B., Pessayre D. Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity. Pharmacol. Ther. 1995, 67:101-154.
28. Garcia-Ruiz I., Rodriguez-Juan C., Diaz-Sanjuan T., del Hoyo P., Colina F., Munoz-Yague T., Solís-Herruzo J.A. Uric acid and anti-TNF antibody improve mitochondrial dysfunction in ob/ob mice. Hepatology 2006, 44:581-591.
29. Garland P.B., Shepherd D., Nicholls D.G., Yates D.W., Light P.A. Interactions between fatty acid oxidation and the tricarboxylic acid cycle. Citric Acid Cycle 1969, 163-212. Dekker, New York. J.M. Lowestein (Ed.).
30. Hissin P.J., Hilf R. A fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal. Biochem. 1976, 74:214-226.
31. Hotamisligil G.S., Peralti S.P., Budavari A., Ellis R., White M.F., Spiegelman B.A. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science 1996, 271:665-668.
32. James O., Day C. Non-alcoholic steatohepatitis: another disease of affluence. Lancet 1999, 353:1634-1636.
33. Kennedy J.A., Unger S.A., Horowitz J.D. Inhibition of carnitine palmitoyltransferase-I in rat heart and liver by perhexiline and amiodarone. Biochem. Pharmacol. 1996, 52:273-280.
34. Kern P.A., Saghizaheh M., Ong J.M., Bosch R.J., Deem R., Simsolo R.B. The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. J. Clin. Invest. 1995, 95:2111-2119.
35. Kersten S., Seydoux J., Peters J.M., Gonzalez F.J., Desvergne B., Wahli W. Peroxisome proliferator-activated receptor-α mediates the adaptive response to fasting. J. Clin. Invest. 1999, 103:1489-1498.
36. Kim J.Y., Koves T.R., Yu G.S., Gulick T., Cortright R.N., Dohm G.L., Muoio D.M. Evidence of a malonyl-CoA-insensitive carnitine palmitoyltransferase I activity in red skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 2002, 282:E1014-E1022.
37. Kim Y.W., Choi D.W., Park Y.H., Huh J.Y., Won K.C. Leptin-like effects of MTII are augmented in MSG-obese rats. Regul. Pept. 2005, 127:63-70.
38. Kletzien R.F., Harris P.K., Foellmi L.A. Glucose-6-phosphate dehydrogenase: a"housekeeping" enzyme subject to tissue-specific regulation by hormones, nutrients and oxidative stress. FASEB J. 1994, 8:174-181.
39. 2+ acting at the external side of the inner mitochondrial membrane can stimulate mitochondrial permeability transition induced by phenylarsine oxide. Biochim. Biophys. Acta. 1997, 1322:221-229.
40. Kowaltowski A.J., Castilho F.R., Vercesi A.E. Mitochondrial permeability transition and oxidative stress. FEBS Lett. 2001, 495:12-15.
41. Lee Y., Wang M.Y., Kakuma T., Wang Z.W., Babcock E., McCorkle K., Higa M., Zhou Y.T., Unger R.H. Liporegulation in diet-induced obesity. The antisteatotic role of hyperleptinemia. J. Biol. Chem. 2001, 276:5629-5635.
42. Lorden J.F., Caudle A. Behavioral and endocrinological effects of single injections of monosodium glutamate in the mouse. Neurobehav. Toxicol. Teratol. 1986, 8:509-519.
43. Louet J.F., Chatelain F., Decaux J.F., Park E.A., Kohl C., Pineau T., Girard J., Pegorier J.P. Long-chain fatty acid regulates liver carnitine palmitoyltransferase I gene (L-CPT I) expression through a peroxisome proliferator-activated receptor-α (PPAR-α)-independent pathway. Biochem. J. 2001, 354:189-197.
44. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951, 193:265-275.
45. Macho L., Ficková M., Jezová, Zórad S. Late effects of postnatal administration of monosodium glutamate on insulin action in adult rats. Physiol. Res. 2000, 49:79-85.
46. Marklund S., Marklund G. Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur. J. Biochem. 1974, 47:469-474.
47. Memon R.A., Tecott L.H., Nonogaki K., Beigneux A., Moser A.H., Grunfeld C., Feingold K.R. Up-regulation of peroxisome proliferator-activated receptors (PPAR-α) and PPAR-γ messenger ribonucleic acid expression in the liver in murine obesity: troglitazone induces expression of PPAR-γ-responsive adipose tissue-specific genes in the liver of obese diabetic mice. Endocrinology 2000, 41:4021-4031.
48. Mize C.E., Langdon R.G. Hepatic glutathione reductase. Purification and general kinetic properties. J. Biol. Chem. 1962, 237:1589-1595.
49. Nakatani T., Tsuboyama-Kasaoka N., Takahashi M., Miura S., Ezaki O. Mechanism for peroxisome proliferator-activated receptor-α activator-induced up-regulation of UCP-2 mRNA in rodent hepatocytes. J. Biol. Chem. 2002, 277:9562-9569.
50. Naoi T., Shibuya N., Inoue H., Mita S., Kobayashi S., Watanabe K., Orino K. The effect of tert-butylhydroquinone-induced oxidative stress in MDBK cells using XTT assay: implication of tert-butylhydroquinone-induced NADPH generating enzymes. J. Vet. Med. Sci. 2010, 72:321-326.
51. Natarajan S.K., Eapen C.E., Olimood A.B., Balasubramanian K.A. Oxidative stress in experimental liver microvesicular steatosis: role of mitochondria and peroxisomes. Hepatology 2006, 21:1240-1249.
52. Negre-Salvayre A., Hirtz C., Carrera G., Cazenave R., Troly M., Salvayre R., Pénicaud L., Casteilla L. A role for uncoupling protein-2 as a regulator of mitochondrial hydrogen peroxide generation. FASEB J. 1997, 11:809-815.
53. Nikoletseas M.M. Obesity in exercising, hypohagic rats treated with monosodium glutamate. Physiol. Behavior 1977, 19:767-773.
54. Noland R.C., Tracey L., Woodlief B.R., Manning S.M., Evans J.R., Dudek R.W., Lust R.M., Cortright R.N. Peroxisomal-mitochondrial oxidation in a rodent model of obesity-associated insulin resistance. Am. J. Physiol. Endocrinol. Metabol. 2007, 293:E986-E1001.
55. Olney J.W. Brain lesions, obesity and other disturbances in mice treated with monosodium glutamate. Science 1969, 164:719-721.
56. Paglia E.D., Valentine W.N. Studies on the quantitative and qualitative characterization of erythrocyte glutatione peroxidase. J. Lab. Clin. Med. 1967, 70:158-169.
57. Park J., Rho H.K., Kim K.H., Choe S.S., Lee Y.S., Kim J.B. Overexpression of glucose-6-phosphate dehydrogenase is associated with lipid dysregulation and insulin resistance in obesity. Mol. Cell. Biol. 2005, 25:5146-5157.
58. Park J., Choe S.S., Choi A.H., Kim K.H., Yoon M.J., Suganami T., Ogawa Y., Kim J.B. Increase in glucose-6-phosphate dehydrogenase in adipocytes stimulates oxidative stress and inflammatory signals. Diabetes 2006, 55:2939-2949.
59. Perez-Carreras M., Del Hoyo P., Martin M.A., Rubio J.C., Martin A., Castellano G., Colina F., Arenas J., Solís-Herruzo J.A. Defective hepatic mitochondrial respiratory chain in patients with non-alcoholic steatohepatitis. Hepatology 2003, 38:999-1007.
60. Rector R.S., Thyfault J.P., Wei Y., Ibdah J.A. Non-alcoholic fatty liver disease and the metabolic syndrome: an update. World J. Gastroenterol. 2008, 14:185-192.
61. Rector R.S., Thyfault J.P., Uptergrove G.M., Morris E.M., Naples S.P., Borengasser S.J., Mikus C.R., Laye M.J., Laughlin M.H., Booth F.W., Ibdah J.A. Mitochondrial dysfunction precedes insulin resistance and hepatic steatosis and contributes to the natural history of non-alcoholic fatty liver disease in an obese rodent model. J. Hepatol. 2010, 52:727-736.
62. Riu E., Bosch F., Valera A. Prevention of diabetic alterations in transgenic mice overexpressing Myc in the liver. Proc. Natl. Acad. Sci. USA 1996, 93:2198-2202.
63. Sanyal A.J., Campbell-Sargent C., Mirshahi F., Rizzo W.B., Contos M.J., Sterling R.K., Luketic V.A., Shiffman M.L., Clore J.N. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 2001, 120:1183-1192.
64. Singh A., Wirtz M., Parker N., Hogan M., Strahler J., Michailidis G., Schmidt S., Vidal-Puig A., Diano S., Andrews P., Brand M.D., Friedman J. Leptin-mediated changes in hepatic mitochondrial metabolism, structure, and protein levels. Proc. Natl. Acad. Sci. USA 2009, 106:13100-13105.
65. St-Pierre J., Buckingham J.A., Roebuck S.J., Brand M.D. Topology of superoxide production from different sites in the mitochondrial electron transport chain. J. Biol. Chem. 2002, 277:44784-44790.
66. Takasaki Y. Studies on brain lesion by administration of monosodium l-glutamate to mice. I. Brain lesions in infant mice caused by administration of monosodium L-glutamate. Toxicology 1978, 9:293-305.
67. Tian W.N., Pignatare N., Stanton R.C. Signal transduction proteins that associate with the platelet-derived growth factor (PDGF) receptor mediate the PDGF-induced release of glucose-6-phosphate dehydrogenase from permeabilized cells. J. Biol. Chem. 1994, 269:14798-14805.
68. Tian W.N., Braunstein L.D., Pang J., Stuhlmeier K.M., Xi Q.C., Tian X., Stanton R.C. Importante of glucose-6-phophate dehydrogenase activity for cell growth. J. Biol. Chem. 1998, 273:10609-10617.
69. Turner N., Bruce C.R., Beale S.M., Hoehn K.L., So T., Rolph M.S., Cooney G.J. Excess lipid availability increases mitochondrial fatty acid oxidative capacity in muscle: evidence against a role for reduced fatty acid oxidation in lipid-induced insulin resistance in rodents. Diabetes 2007, 56:2085-2092.
70. Ulrich R.G., Bacon J.A., Cramer C.T., Petrella D.K., Sun E.L., Meglasson M.D., Holmuhamedov E. Disruption of mitochondrial activity in rabbit and human hepatocytes by a quinoxalinone anxiolytic and its carboxylic acid metabolite. Toxicology 1998, 131:33-47.
71. Uysal K.T., Wiesbrock S.M., Marino M.W., Hotamisligil G.S. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 1997, 389:610-614.
72. Vijayalakshmi T., Jayaprakash N.P., Sachdanandam P. Changes in glucose metabolising enzymes in adjuvant arthritis and its treatment with a Siddha drug: Serankottai Nei. Indian. J. Pharmacol. 1998, 30:89-93.
73. Yang S., Zhu H., Li Y., Lin H., Gabrielson K., Trush M.A., Diehl A.M. Mitochondrial adaptations to obesity-related oxidant stress. Arch. Biochem. Biophys. 2000, 378:259-268.